Partnering for Progress in Psychedelic Care
As clinical interest in psychedelic medicine grows, patients and providers alike face a landscape filled with both hope and misinformation. At PSI, we understand your commitment to your patients and your need for partnerships built on scientific rigor, ethical practice, and transparent collaboration. We speak as colleagues, honoring your existing treatment goals and inviting a partnership that advances healing responsibly.
Why Partner with PSI TRIP Clinics?
PSI TRIP Clinics represent the merging of experience with innovation in psychedelic care. Our foundation is built on decades of expertise in psychiatry, neuroscience, and clinical trial ethics, with a team certified in trauma-informed and culturally responsive care. We are more than a typical treatment center; we are conducting clinical trials focused on developing the next generation of mental health care and psychedelic medicine.
- Clear Differentiation: We clearly differentiate between our clinical trial opportunities and standard care offerings, ensuring you understand the appropriate pathways for your patients.
- Rigorous Medical Protocols: All our services adhere to clear medical protocols, emphasizing safety and ethical considerations from screening through integration. Our protocols are developed and delivered by professionals with decades of experience in psychiatry, neuroscience, and trial ethics, alongside certifications in trauma-informed and culturally responsive care.
- Expert, Licensed Providers: Our team comprises licensed physicians, nurses, psychologists, and psychotherapists with specialized training in psychedelic-assisted therapy and trauma-informed care. The California Center for Psychedelic Therapy, now part of PSI, is the longest-standing mental health clinic working with ketamine-assisted psychotherapy in Southern California.
- Data-Driven Insights: We can provide outcomes, consultation and collaborative treatment planning regarding your patients' progress and goals, supporting continuity of care. Our commitment to treatment collaboration aims to enhance collective understanding and support of each patient's individual needs.
- Feedback Loops: We value collaboration and offer feedback loops with referring providers to ensure a seamless and informed care journey for your patients.
Referral Opportunities
PSI TRIP Clinics offer both treatments with psychedelic-assisted therapy and innovative clinical trial opportunities for conditions that may not have responded to other available therapies.
Ketamine-Assisted Psychotherapy (KAP)
Conditions Treated: Major Depression, Treatment-Resistant Depression, Post-Traumatic Stress Disorder (PTSD), Anxiety disorders, Obsessive-Compulsive Disorder (OCD), Bipolar Depression, Adjustment DIsorders and End-of-Life Psychological Care, Palliative Care, Drug and Alcohol Use Disorders.
Process: KAP involves a series of in-clinic ketamine-assisted psychotherapy sessions conducted by licensed medical and psychological health care providers. Patients must be California residents and attend in-person dosing sessions at our Santa Monica or Hollywood TRIP Clinics.
Cost: Ketamine dosing sessions are $600 out-of-pocket, 2 times a week for 8 weeks. Ketamine is FDA-approved as an anesthetic and used "off-label" for KAP.
Psychedelic Integration Therapy
Designed to support the synthesis of mind and body after experiencing non-ordinary states of consciousness. This service is for patients seeking to process psychedelic experiences from a range of various contexts — ceremonial, recreational and/or medical — offering a harm-reduction approach and clinical support for meaningful change.
Psychotherapy
Our team of trauma-informed psychotherapists offers comprehensive, depth-oriented psychotherapy, including Transpersonal, Supportive, Interpersonal, and Psychodynamic approaches.
Psychotherapy is an effective treatment for people experiencing a wide range of mental health challenges, from depression, traumatic stress and anxiety to relationship challenges and other existential crises.
Medication Management
Our medical team provides evaluation, consultation and supervision of medication regimens, focusing on maximizing quality of life with the minimum necessary treatment. This can be combined with psychotherapy to optimize outcomes or offered as a stand alone treatment option.
Psychedelic-Assisted Clinical Trials
PSI is actively involved in clinical trials for multiple psychedelic compounds including psilocybin, LSD DMT, and other novel psychedelics. Available trials vary at times, but may include studies for Major Depressive Disorder, Treatment-Resistant Depression, Generalized Anxiety Disorder and PTSD.
View currently-enrolling trials
Past Completed Trials include studies for Post Traumatic Stress Disorder, Generalized Anxiety Disorder, Treatment Resistant Depression, Major Depressive Disorder, Postpartum Depression and Alcohol Use Disorder.
Important Note: MDMA, psilocybin, LSD and DMT have not been approved by any regulatory agency. The safety and efficacy of these investigational products have not yet been fully established for the treatment of any health conditions. PSI clinicians have extensive research experience with these emerging treatments.
How to Refer:
Telehealth: Our specialists offer HIPAA-compliant telehealth visits for patients anywhere in California for psychotherapy services. Ketamine-assisted psychotherapy, clinical trials and medication management services all require onsite, in clinic visits.
Clinical Practice Guidelines & Oversight
At PSI/TRIP, safety and integrity are paramount. We adhere to rigorous clinical practice guidelines and maintain transparent oversight to ensure the highest quality of patient care and research.
Expert Oversight:
Every care plan, whether for treatment or trials, is conducted by licensed clinicians trained in psychedelic and trauma-informed care. Our multidisciplinary team includes experienced physicians, psychologists, psychiatric nurses and other mental health experts.
Science-Backed Protocols:
All our services are legal, evidence-informed, and client-centered. We conduct regulated clinical trial protocols and our treatment plans rely on peer-reviewed evidence to support patient safety and scientific rigor, crucial for treatment efficacy.
Patient-Centered Approach:
Participant-centered design leads to higher trust and lower dropout rates. We embrace a relational, "set and setting" framework to optimize the therapeutic experience, ensuring patients are fully consented, screened, prepared, supported throughout all services at PSI.
Ethical Practices:
PSI founders and staff are dedicated to not only providing, but pioneering safe and ethical practices within psychedelic medicine. Due to the ongoing negative impacts of drug policies, we do not provide or endorse the use of illegal substances.
Clear Communication:
We can provide clinical outcomes and consultation to referring providers, supporting continuity of care. We also offer transparent, consistent communication including informed consent and collaborative treatment planning to help build a foundation of trust. We can provide consultation to referring providers and warm handoffs at the conclusion of our services to facilitate seamless collaboration.
Partner with PSI
We welcome collaboration and are ready to discuss how PSI can serve as a valuable extention of your patient care.
To learn more or to discuss referring a patient:
- For Ketamine Treatment: 310-996-8966
- For Psychedelic-Assisted Clinical Trials: 310-378-0303